ASPEN PHARMACARE HOLDINGS LIMITED - Pre-Closed Period Conference Call
APN 201409030028A
Pre-Closed Period Conference Call
ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number: 1985/0002935/06
Share code: APN
ISIN: ZAE000066692
(“Aspen” or “the Company”)
PRE-CLOSED PERIOD CONFERENCE CALL
The Company refers to the disclosures made by Aspen’s executive directors during a pre-closed period
conference call with members of the investment community on 27 June 2014 (“the Conference Call”) and
the subsequent SENS announcement dated 30 June 2014.
Based on the representations made by the Company to the JSE, as well as the relevant facts gathered by
the JSE in respect of this matter, the JSE has informed the Company that it did not find any breach of the
JSE’s Listings Requirements as the contents of the Conference Call were already in the public domain
and/or were not materiality price sensitive if understood in its context. The investigation was thus closed
by the JSE.
Durban
3 September 2014
Sponsor:
Investec Bank Limited
Date: 03/09/2014 01:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
